Sandeep Kalra, CEO, Persistent Systems said margins were supported by growing use of its AI platforms — SASVA, iAURA and ...
AI can accelerate drug discovery, clinical development, and patient access, but regulatory hurdles remain. Anders Romare, ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果